ROLE OF PKC IN CELL TURNOVER IN THE MAMMARY GLAND
ROLE OF PKC IN CELL TURNOVER IN THE MAMMARY GLAND
批准号:
7018039
负责人:
MARY ELAINE REYLAND
金额:
$16.05万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2010-05-31
关键词:
SDS polyacrylamide gel electrophoresisapoptosisbiological signal transductioncell growth regulationenzyme activityenzyme mechanismgene expressiongenetically modified animalsimmunocytochemistryinterleukin 6laboratory mousemammary epitheliummammary glandprolactinprotein kinase Cprotein metabolismprotein structure functionreproductive developmentreproductive system disordertranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mammary gland development and involution are complex processes which are regulated in part through dynamic changes in cell proliferation and apoptosis. In the mammary gland apoptosis contributes to ductal development and is essential for the clearance of mammary epithelial cells during post-lactational involution. Protein kinase Cdelta (PKCdelta) is a ubiquitously expressed isoform of the PKC family of serine/threonine kinases, and analysis of the mouse knock-out
of PKCdelta suggests that this isoform regulates both cell proliferation and apoptosis. Our studies indicate that PKCdelta functions early in the apoptotic pathway and we have recently identified Signal Transducer and Activator of Transcription 1 (STAT1) as a downstream target of PKCdelta in apoptotic cells. PKCdelta is also essential for STAT3 activation in cells treated with cytokines and interferon. In the mammary gland, STATS is required for mammary gland
development during pregnancy, while STATS orchestrates mammary gland involution. The central role PKCdelta plays in epithelial cell apoptosis, together with the link between PKC5 and STAT activation, suggests that PKCdelta may be critical for mammary gland homeostasis. In this proposal we will explore the role of PKCdelta in mammary gland development and involution using mice in which the PKCdelta gene has been disrupted (deltaKO mice) and primary
mammary epithelial cells derived from wild type and deltaKO mice. In Aim 1 we will test the hypothesis that loss of PKCdelta in vivo result in suppression or delay of involution and may result in abnormal mammary gland development. We will determine if mammary gland development and/or involution are altered in PKCdelta knock-out (deltaKO) mice, if the mammary gland phenotype in the deltaKO mice is tissue autonomous, and if reconstitution of PKCdelta
can reverse the phenotype. In Aim 2 we will explore the molecular mechanisms by which PKCdelta regulates mammary epithelial cell apoptosis, and we will test the hypothesis that PKCdelta is required for signal transduction downstream of prolactin and the IL6 family cytokines. We will explore PKCdelta activation in response to apoptotic stimuli relevant to involution and determine the functional domains of PKCdelta that are required for
apoptosis in MECs. We will determine if MECs from deltaKO mice are resistant to apoptosis induced by these stimuli and explore the molecular mechanism which underlies this resistance. The proposed studies will enhance our understanding of the signal transduction pathways which regulate mammary gland development and involution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Colorado HNC SPORE Developmental Research Program
-
批准号:10477468
-
项目类别:
-
资助金额:$9.56万
-
财政年份:2021
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Colorado HNC SPORE Developmental Research Program
-
批准号:10704605
-
项目类别:
-
资助金额:$9.56万
-
财政年份:2021
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Colorado HNC SPORE Developmental Research Program
-
批准号:10268848
-
项目类别:
-
资助金额:$10.28万
-
财政年份:2021
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Cancer Research Experiences for Undergraduates (CREU)
-
批准号:9792114
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2019
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Cancer Research Experiences for Undergraduates (CREU)
-
批准号:10460905
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2019
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Cancer Research Experiences for Undergraduates (CREU)
-
批准号:10670888
-
项目类别:
-
资助金额:$29.2万
-
财政年份:2019
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Cancer Research Experiences for Undergraduates (CREU)
-
批准号:9980322
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2019
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and chromatin remodeling
-
批准号:9903645
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2018
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and salivary gland radioprotection
-
批准号:10190894
-
项目类别:
-
资助金额:$48.19万
-
财政年份:2018
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and salivary gland radioprotection
-
批准号:10402350
-
项目类别:
-
资助金额:$47.71万
-
财政年份:2018
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Radio-protection of the salivary gland
-
批准号:8684939
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2014
-
负责人:MARY ELAINE REYLAND
-
依托单位:
FASEB SRC on Lipids and Lipid Regulated Kinases in Cancer
-
批准号:8782705
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2014
-
负责人:MARY ELAINE REYLAND
-
依托单位:
2011 Salivary Glands and Exocrine Biology Gordon Research Conference
-
批准号:8059865
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2011
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and Salivary Gland Apoptosis
-
批准号:7932536
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2009
-
负责人:MARY ELAINE REYLAND
-
依托单位:
2009 Salivary Glands and Exocrine Secretion Gordon Research Conference
-
批准号:7665657
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKC regulation of salivary acinar cell apoptosis
-
批准号:6847153
-
项目类别:
-
资助金额:$11.68万
-
财政年份:2004
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Regulation of Salivary Cell Apoptosis by PKC
-
批准号:6712569
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2003
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and Salivary Gland Apoptosis
-
批准号:7888270
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2003
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and Salivary Gland Apoptosis
-
批准号:7667149
-
项目类别:
-
资助金额:$36.15万
-
财政年份:2003
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and Salivary Gland Apoptosis
-
批准号:8110474
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2003
-
负责人:MARY ELAINE REYLAND
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: